Mangorx receives patent notice of allowance in japan for revolutionary preventive care technology acquired from intramont technologies

Dallas, texas, june 04, 2024 (globe newswire) -- mangoceuticals, inc. (nasdaq: mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ed), hair growth, weight loss and hormone replacement therapies, is pleased to announce that it has received a notice of allowance for japanese patent application no. 2021-545824, originally applied for by intramont technologies, inc. (“intramont”).
MGRX Ratings Summary
MGRX Quant Ranking